These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35368008)

  • 21. Clinical evaluation of the periodontal health condition and oral health awareness in Parkinson's disease patients.
    Pradeep AR; Singh SP; Martande SS; Raju AP; Rustagi T; Suke DK; Naik SB
    Gerodontology; 2015 Jun; 32(2):100-6. PubMed ID: 23718321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
    Karakoc M; Yon MI; Cakmakli GY; Ulusoy EK; Gulunay A; Oztekin N; Ak F
    Neurol Sci; 2016 Dec; 37(12):1987-1991. PubMed ID: 27613712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's Disease Oral Health Module: Interprofessional Coordination of Care.
    Jeter CB; Rozas NS; Sadowsky JM; Jones DJ
    MedEdPORTAL; 2018 Mar; 14():10699. PubMed ID: 30800899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease and oral care.
    Fiske J; Hyland K
    Dent Update; 2000 Mar; 27(2):58-65. PubMed ID: 11218273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drooling rating scales in Parkinson's disease: A systematic review.
    Nascimento D; Carmona J; Mestre T; Ferreira JJ; Guimarães I
    Parkinsonism Relat Disord; 2021 Oct; 91():173-180. PubMed ID: 34583888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
    Rascol O; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Fabbri M; Meissner WG; Rachdi A; Tison F; Perez-Lloret S;
    J Neural Transm (Vienna); 2020 Dec; 127(12):1607-1617. PubMed ID: 32880023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study.
    van Wamelen DJ; Leta V; Johnson J; Ocampo CL; Podlewska AM; Rukavina K; Rizos A; Martinez-Martin P; Chaudhuri KR
    Dysphagia; 2020 Dec; 35(6):955-961. PubMed ID: 32130515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotigotine may control drooling in patients with Parkinson's Disease: Preliminary findings.
    Schirinzi T; Imbriani P; D'Elia A; Di Lazzaro G; Mercuri NB; Pisani A
    Clin Neurol Neurosurg; 2017 May; 156():63-65. PubMed ID: 28342306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialorrhea in Parkinson's Disease.
    Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Hygiene in Patients with Parkinson's Disease.
    Batista LM; Portela de Oliveira MT; Magalhaes WB; Bastos PL
    R I Med J (2013); 2015 Nov; 98(11):35-7. PubMed ID: 26517254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients.
    Ou R; Guo X; Wei Q; Cao B; Yang J; Song W; Shao N; Zhao B; Chen X; Shang H
    Parkinsonism Relat Disord; 2015 Mar; 21(3):211-5. PubMed ID: 25537930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of orofacial physiotherapeutic and hygiene interventions on oral health-related quality of life in patients with Parkinson's disease: A randomised controlled trial.
    Baram S; Karlsborg M; Øzhayat EB; Bakke M
    J Oral Rehabil; 2021 Sep; 48(9):1035-1043. PubMed ID: 34129743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysphagia and sialorrhea: the relationship to Parkinson's disease.
    Nicaretta DH; Rosso AL; Mattos JP; Maliska C; Costa MM
    Arq Gastroenterol; 2013; 50(1):42-9. PubMed ID: 23657306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.
    Reynolds H; Miller N; Walker R
    Dysphagia; 2018 Dec; 33(6):809-817. PubMed ID: 29785679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialorrhea in Parkinson's disease: a review.
    Chou KL; Evatt M; Hinson V; Kompoliti K
    Mov Disord; 2007 Dec; 22(16):2306-13. PubMed ID: 17659637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of three Parkinson's disease patients treated with mandibular implant overdentures.
    Heckmann SM; Heckmann JG; Weber HP
    Clin Oral Implants Res; 2000 Dec; 11(6):566-71. PubMed ID: 11168250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease.
    Cheng YQ; Ge NN; Zhu HH; Sha ZT; Jiang T; Zhang YD; Tian YY
    Parkinsonism Relat Disord; 2019 Jan; 58():70-73. PubMed ID: 30177490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of and the factors associated with drooling in Parkinson's disease.
    Leibner J; Ramjit A; Sedig L; Dai Y; Wu SS; Jacobson C; Okun MS; Rodriguez RL; Malaty IA; Fernandez HH
    Parkinsonism Relat Disord; 2010 Aug; 16(7):475-7. PubMed ID: 20064737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.